Home/Filings/4/0001140361-09-024091
4//SEC Filing

Ghazvini Siavash 4

Accession 0001140361-09-024091

CIK 0000830736other

Filed

Oct 28, 8:00 PM ET

Accepted

Oct 29, 5:19 PM ET

Size

15.4 KB

Accession

0001140361-09-024091

Insider Transaction Report

Form 4
Period: 2009-10-28
Ghazvini Siavash
VP - Marketing & Business Dev
Transactions
  • Disposition to Issuer

    Common Stock

    2009-10-28175,5000 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-10-2825,1440 total
    Exercise: $2.62Exp: 2013-09-15Common Stock (25,144 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-10-28$0.15/sh25,000$3,7500 total
    Exercise: $1.35Exp: 2016-05-24Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (Riht to Buy)

    2009-10-28$0.52/sh30,000$15,6000 total
    Exercise: $0.98Exp: 2018-06-16Common Stock (30,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2009-10-28$0.62/sh30,000$18,6000 total
    Exercise: $0.88Exp: 2019-09-01Common Stock (30,000 underlying)
Footnotes (5)
  • [F1]Disposed of pursuant to a merger agreement between the Issuer and Cell Biosciences, Inc. in exchange for a cash payment of $1.50 per share on the effective date of the merger.
  • [F2]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled on the effective date of the merger.
  • [F3]This option, which provided for monthly vesting in equal installments over four years, was canceled in the merger in exchange for a cash payment of $3,750, representing the difference between the exercise price of the option and the merger price ($1.50 per share).
  • [F4]This option, which provided for monthly vesting in equal installments over four years, was canceled in the merger in exchange for a cash payment of $15,600, representing the difference between the exercise price of the option and the merger price ($1.50 per share).
  • [F5]This option, which provided for vesting at the rate of 25% after one year and monthly vesting of the remainder in equal installments over the following three years, was canceled in the merger in exchange for a cash payment of $18,600, representing the difference between the exercise price of the option and the merger price ($1.50 per share).

Documents

1 file

Issuer

ALPHA INNOTECH CORP

CIK 0000830736

Entity typeother

Related Parties

1
  • filerCIK 0001397793

Filing Metadata

Form type
4
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 5:19 PM ET
Size
15.4 KB